Ritelth Medipharma Private Limited, a active private limited company, was established on 04 February 2016 in Thane, Maharashtra, India. Engaging in drug formulation & development within the hospital and medical care sector, it holds CIN: U24100MH2016PTC272679. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.30 M.
Formerly known as Merk Medipharma Private Limited. It upholds a compliant status. Its leadership includes Hemant Sajanrao Shewale (Director), Balasaheb Tukaram Mohite (Director), Krishna Bhaskar Nimsakhare (Director). It holds ₹2.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at Office No.101,Madhupushpa Chs, Near Bramhan Vidyalaya, Charai, Thane We, St,, Thane, Maharashtra, 400601.
U24100MH2016PTC272679
272679
04 February 2016
₹1.00 M
₹0.30 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Ritelth Medipharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Hemant Sajanrao Shewale | Director | 04 Feb 2016 | Current |
| Balasaheb Tukaram Mohite | Director | 04 Feb 2016 | Current |
| Krishna Bhaskar Nimsakhare | Director | 04 Feb 2016 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ritelth Medipharma Private Limited, for the financial year ended 2019, experienced modest growth in revenue, with a 1.13% increase. The company also saw a substantial fall in profitability, with a 121.75% decrease in profit. The company's net worth observed a substantial decline by a decrease of 32.43%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Ritelth Medipharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹2,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Jul 2018 | Others | ₹2.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Ritelth Medipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ritelth Medipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ritelth Medipharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ritelth Medipharma Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was recorded as a recent event.
Ritelth Medipharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 2.00 M with Charge ID 100196972 was registered on 21 Jul 2018. was documented.
The activity Hemant Sajanrao Shewale was appointed as a Director was appointed as a Director on 04 Feb 2016 & has been associated with this company since 9 years 10 months . was completed.
The activity Balasaheb Tukaram Mohite was appointed as a Director was appointed as a Director on 04 Feb 2016 & has been associated with this company since 9 years 10 months . was completed.
Progress on Krishna Bhaskar Nimsakhare was appointed as a Director was appointed as a Director on 04 Feb 2016 & has been associated with this company since 9 years 10 months . was documented.
The CIN of Ritelth Medipharma Private Limited is U24100MH2016PTC272679.
Ritelth Medipharma Private Limited is headquartered at Office No.101,Madhupushpa Chs, Near Bramhan Vidyalaya, Charai, Thane We, St,, Thane, Maharashtra, 400601.
Ritelth Medipharma Private Limited was incorporated on 04 February 2016.
The current directors of Ritelth Medipharma Private Limited are
The primary industry of Ritelth Medipharma Private Limited is Hospital And Medical Care.
Ritelth Medipharma Private Limited is unlisted.
The authorized capital of Ritelth Medipharma Private Limited is ₹1.00 M, and the paid-up capital is ₹0.30 M.
The compliance status of Ritelth Medipharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX